Wei Zuo, PhD (he/him/his)

Tongji University, China

Wei Zuo, Full Professor and Deputy Director of Tongji Stem Cell Center, Tongji University, serves as Vice-President of the Chinese Cell & Gene Therapy Society. A pioneer in translational medicine, he drives innovation in airway stem cell therapy. After establishing murine airway stem cell culture systems (Nature 2015), Zuo pioneered pharmaceutical-grade P63+ human airway basal stem cell culture and bronchoscopic transplantation (Protein Cell 2018; Nature Commun 2025). His breakthrough therapies for COPD, IPF and bronchiectasis demonstrate lung function recovery and lifespan extension in NMPA-approved Phase II trials, with findings published in Science Translational Medicine, Cell Reports Medicine, and eLife (all 2024). This first-in-class approach opens new regenerative pathways for lethal pulmonary diseases.

Presentation(s):

• CLINICAL TRANSLATION OF BIOENGINEERED TISSUE-BASED THERAPEUTICS

  Friday, June 13, 2025
  8:30 AM – 10:00 AM HK Time

• AUTOLOGOUS TRANSPLANTATION OF AIRWAY BASAL STEM CELLS IN COPD PATIENTS: A RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL

  Friday, June 13, 2025
  9:05 AM – 9:15 AM HK Time